Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models

Behavioural Brain Research

Volumn 209, Issue 1, 2010, Pages 93-98

  Sziray, Nóra ^a   Kuki, Zsófia ^a   Nagy, Katalin M ^a   Markó, Bernadett ^a   Kompagne, Hajnalka ^a   Lévay, György ^a,b  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

5 HT system; Anxiolytic like; Elevated plus maze; Lesion; Light dark transitions; NA system; Simultaneous

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 5,7 DIHYDROXYTRYPTAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

5,7-DIHYDROXYTRYPTAMINE; ADAPTATION, PHYSIOLOGICAL; ADRENERGIC AGENTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANXIETY; BENZYLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIPRAMINE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FLUOXETINE; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MOTOR ACTIVITY; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS; SPATIAL BEHAVIOR;

EID: 77349114666     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.01.019     Document Type: Article

References (55)

1. Adams RN, Marsden CA. Electrochemical detection methods for monoamine measurements in vitro and in vivo. In: Handbook of psychopharmacology, vol. 15. New York: Plenum Press; 1982. p. 1-74 [chapter 1].
2. Andrade T.G., and Graeff F.G. Effect of electrolytic and neurotoxic lesions of the median raphe nucleus on anxiety and stress. Pharmacol Biochem Behav 70 1 (2001) 1-14
3. Baraban J.M., and Aghajanian G.K. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res 204 (1981) 1-11
4. Bilkei-Gorzó A., Gyertyán I., and Lévay G. mCPP-induced anxiety in the light-dark box in rats- a new method for screening anxiolytic activity. Psychopharmacology 136 (1998) 291-298
5. Borsy J., Csanyi E., and Lazar I. A method of assaying tranquilizing drugs based on the inhibition of orientational hypermotility. Arch Int Pharmacodyn Ther 124 (1960) 180-190
6. Bourin M. Animal models of anxiety: are they suitable for predicting drug action in humans?. Pol J Pharmacol 49 2-3 (1997) 79-84
7. Bourin M., and Hascoët M. The mouse light/dark box test. Eur J Pharmacol 463 1-3 (2003) 55-65
8. Briley M., Chopin P., and Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology (Berl) 101 2 (1990) 187-189
9. Carli M., Prontera C., and Samanin R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br J Pharmacol 96 4 (1989) 829-836
10. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32 3 (1989) 777-785 PMID: 2740429
11. Feldman S., and Weidenfeld J. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res Bull 45 4 (1998) 389-393
12. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125 1-2 (2001) 151-157
13. File S.E., Hyde J.R., and MacLeod N.K. 5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord 1 2 (1979) 115-122
14. Fontana D.J., McMiller Jr. L.V., and Commissaris R.L. Depletion of brain norepinephrine: differential influence on anxiolyic treatment effects. Psychopharmacology (Berl) 143 2 (1999) 197-208
15. Frechilla D., Insausti R., Ruiz-Golvano P., García-Osta A., Rubio M.P., Almendral J.M., et al. Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum. Brain Res Mol Brain Res 76 2 (2000) 306-314
16. Fritschy J.M., and Grzanna R. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?. Prog Brain Res 88 (1991) 257-268
17. Graeff F.G., Guimarães F.S., De Andrade T.G., and Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54 1 (1996) 129-141
18. Graeff F.G., Viana M.B., and Mora P.O. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 21 6 (1997) 791-799
19. Griebel G., Belzung C., Perrault G., and Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 148 2 (2000) 164-170
20. Hall F.S., Devries A.C., Fong G.W., Huang S., and Pert A. Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior. Synapse 33 1 (1999) 16-25
21. Harro J., Jossan S.S., and Oreland L. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment. Naunyn Schmiedebergs Arch Pharmacol 346 4 (1992) 425-431
22. Harro J., Oreland L., Vasar E., and Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 5 4 (1995) 447-455
23. Jonsson G., Hallman H., Ponzio F., and Ross S. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)-a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72 (1981) 173-188
24. Kaehler S.T., Singewald N., and Philippu A. Dependence of serotonin release in the locus coeruleus on dorsal raphe neuronal activity. Naunyn Schmiedebergs Arch Pharmacol 359 5 (1999) 386-393
25. Kask A., Eller M., Oreland L., and Harro J. Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat. Neuropeptides 34 1 (2000) 58-61
26. Kask A, Rägo L, Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 1998;30;788(1-2):345-8.
27. Lapiz M.D., Mateo Y., Durkin S., Parker T., and Marsden C.A. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze. Psychopharmacology (Berl) 155 3 (2001) 251-259
28. Massé F., Hascoët M., Dailly E., and Bourin M. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test. Psychopharmacology (Berl) 183 4 (2006) 471-481
29. Mathiasen L.S., Mirza N.R., and Rodgers R.J. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav 90 1 (2008) 19-36
30. McCool B.A., and Chappell A. Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent. Behav Brain Res 178 1 (2007) 70-81
31. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 2 (2003) 83-244
32. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100 15 (2003) 8987-8992
33. Netto S.M., Silveira R., Coimbra N.C., Joca S.R., and Guimarães F.S. Anxiogenic effect of median raphe nucleus lesion in stressed rats. Prog Neuropsychopharmacol Biol Psychiatry 26 6 (2002) 1135-1141
34. Ogasawara T., Itoh Y., Tamura M., Ukai Y., Yoshikuni Y., and Kimura K. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacol Biochem Behav 53 2 (1996) 391-399
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Deluxe 4th ed. USA: Academic Press; 1998.
36. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 3 (1985) 149-167
37. Plaznik A., Jessa M., and Nazar M. The behavioral effects of NMDA antagonists in serotonin depleted rats. Pharmacol Biochem Behav 58 1 (1997) 159-166
38. Pum M.E., Huston J.P., and Müller C.P. The role of cortical serotonin in anxiety and locomotor activity in Wistar rats. Behav Neurosci 123 2 (2009) 449-454
39. Ramos A., Pereira E., Martins G.C., Wehrmeister T.D., and Izídio G.S. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 193 2 (2008) 277-288
40. Rex A., Thomas H., Hörtnagl H., Voits M., and Fink H. Behavioural and microdialysis study after neurotoxic lesion of the dorsal raphe nucleus in rats. Pharmacol Biochem Behav 74 3 (2003) 587-593
41. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 8 6-7 (1997) 477-496 discussion 497-504
42. Romano A.G., Quinn J.L., Liu R., Dave K.D., Schwab D., Alexander G., et al. Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo. Psychopharmacology (Berl) 184 (2006) 173-181
43. Shimizu H., Tatsuno T., Tanaka H., Hirose A., Araki Y., and Nakamura M. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test. Jpn J Pharmacol 59 1 (1992) 105-112
44. Sommer W., Möller C., Wiklund L., Thorsell A., Rimondini R., Nissbrandt H., et al. Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology 24 4 (2001) 430-440
45. Söderpalm B., and Engel J.A. The 5,7-DHT-induced anticonflict effect is dependent on intact adrenocortical function. Life Sci 51 5 (1992) 315-326
46. Srinivasan J., and Schmidt W.J. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats. J Neural Transm 111 1 (2004) 13-26
47. Svensson A.I., Berntsson A., Engel J.A., and Söderpalm B. Disinhibitory behavior and GABA(A) receptor function in serotonin-depleted adult male rats are reduced by gonadectomy. Pharmacol Biochem Behav 67 3 (2000) 613-620
48. Sziray N., Leveleki C., Levay G., Markó B., Hársing Jr. L.G., Mikics E., et al. Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: the role of serotonin/noradrenaline balance and NMDA receptors. Brain Res Bull 71 4 (2007) 376-385
49. Takao K., and Miyakawa T. Light/dark transition test for mice. J Vis Exp 1 (2006) 104
50. Takao K., Nagatani T., Kasahara K., and Hashimoto S. Role of the central serotonergic system in the anticonflict effect of d-AP159. Pharmacol Biochem Behav 43 2 (1992) 503-508
51. Towle A.C., Breese G.R., Mueller R.A., Coyle S., and Lauder J.M. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals. Brain Res 310 (1984) 67-75
52. Volpe B.T., Hendrix C.S., Park D.H., Towle A.C., and Davis H.P. Early post-natal administration of 5,7-dihydroxytryptamine destroys 5-HT neurons but does not affect spatial memory. Brain Res 589 2 (1992) 262-267
53. Winstanley C.A., Theobald D.E., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology(Berl) 176 (2004) 376-385
54. Zhang Z., Rickard J.F., Body S., Asgari K., Bradshaw C.M., and Szabadi E. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine. Psychopharmacology (Berl) 181 (2005) 381-391
55. Zhou F.C., Bledsoe S., and Murphy J. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain. Brain Res 556 1 (1991) 108-116